Insider · CIK 0001644137

Baldry Mark

Reports to the SEC for 3 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001644137

Forms 4 and 5

Insider transactions

18 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-05-16	XFORX4 Pharmaceuticals, IncA Award	Chief Commercial Officer	AAward	+1,032 sh	$2.48	+$2,561.424	25,337
2025-05-16	XFORX4 Pharmaceuticals, IncP Purchase	Chief Commercial Officer	PPurchase	+1,032 sh	$2.48	+$2,561.424	25,337
2025-02-12	XFORX4 Pharmaceuticals, IncA Award	Chief Commercial Officer	AAward	+600K sh	—	—	729,173
2025-01-24	XFORX4 Pharmaceuticals, IncS Sale	Chief Commercial Officer	SSale	−29.2K sh	$0.45	−$13.2K	94,123
2025-01-23	XFORX4 Pharmaceuticals, IncA Award	Chief Commercial Officer	AAward	+74.8K sh	—	—	123,282
2024-11-15	XFORX4 Pharmaceuticals, IncP Purchase	Chief Commercial Officer	PPurchase	+13.4K sh	$0.34	+$4,597.572	129,173
2024-10-07	XFORX4 Pharmaceuticals, IncS Sale	Chief Commercial Officer	SSale	−11.1K sh	$0.58	−$6,505.957	48,509
2024-10-04	XFORX4 Pharmaceuticals, IncA Award	Chief Commercial Officer	AAward	+34.9K sh	—	—	59,636
2024-05-17	XFORX4 Pharmaceuticals, IncP Purchase	Chief Commercial Officer	PPurchase	+21.6K sh	$0.68	+$14.7K	115,769
2024-02-13	XFORX4 Pharmaceuticals, Inc · Stock Appreciation RightA Award	Chief Commercial Officer	AAward	+523K sh	—	—	523,414
2023-11-01	XFORX4 Pharmaceuticals, IncS Sale	Chief Commercial Officer	SSale	−10.3K sh	$0.73	−$7,487.61	24,690
2023-10-31	XFORX4 Pharmaceuticals, IncA Award	Chief Commercial Officer	AAward	+34.9K sh	—	—	34,947
2022-11-03	XFORX4 Pharmaceuticals, Inc · Stock Option (right to buy)A Award	Chief Commercial Officer	AAward	+341K sh	$1.89	+$644K	341,000
2019-08-05	WVEWave Life Sciences, Inc. · Share Option (right to buy)A Award	Chief Commerical Officer	AAward	+25K sh	—	—	25,000
2019-08-05	WVEWave Life Sciences, Inc.A Award	Chief Commerical Officer	AAward	+35K sh	—	—	35,000
2019-08-05	WVEWave Life Sciences, Inc.A Award	Chief Commerical Officer	AAward	+4,000 sh	—	—	39,000
2015-06-01	AMICUS THERAPEUTICS, INC.Stock options (right to buy)A Award	VP Global Marketing	AAward	+50K sh	—	—	50,000
2015-06-01	AMICUS THERAPEUTICS, INC.A Award	VP Global Marketing	AAward	+25K sh	—	—	25,000

Recent filings

Accepted (ET)
Jun 34/A
Baldry Mark0001628280-25-029113
SEC(opens sec.gov)
May 204
Baldry Mark0001628280-25-026864
SEC(opens sec.gov)
Feb 144
Baldry Mark0001628280-25-005698
SEC(opens sec.gov)
Jan 274
Baldry Mark0001628280-25-002707
SEC(opens sec.gov)
Oct 84
Baldry Mark0001628280-24-042544
SEC(opens sec.gov)
Feb 164
Baldry Mark0001628280-24-005380
SEC(opens sec.gov)
Nov 34
Baldry Mark0001628280-23-036756
SEC(opens sec.gov)
Nov 24
Baldry Mark0001628280-23-036466
SEC(opens sec.gov)
Nov 44
Baldry Mark0001628280-22-028462
SEC(opens sec.gov)
Aug 74
Baldry Mark0000899243-19-021293
SEC(opens sec.gov)
Jun 44
AMICUS THERAPEUTICS INC0001209191-15-050290
SEC(opens sec.gov)

Companies

Address

C/O X4 PHARMACEUTICALS, INC. 61 NORTH BEACON STREET 4TH FLOOR

BOSTON, MA, 02134